Moderna’s new vaccine plant will be set up in Laval

The company announced Thursday that it had signed, at the beginning of July, a purchase contract with the National Institute for Scientific Research (INRS) for land at the Laval biotechnology park.

Laval Mayor Stéphane Boyer’s communications team confirms Moderna’s purchase offer.

This site offers enormous synergy opportunities for Moderna thanks to its proximity to a renowned research institution and corresponds to the requirements of the project and its importance for all Quebecers and Canadians.mentions the company in a press release.

For his part, Stéphane Boyer reacted in a Facebook post published on Thursday. Adding a major player like Moderna to our Cité de la biotech in Laval is a real privilege! he wrote. We welcome Moderna today with enthusiasm and will follow the continuation of this file with great attention.

It will also be Moderna’s first plant outside of the United States.

Construction, valued at $180 million, is expected to begin in 2022. The plant could be operational by the end of 2024, according to Moderna estimates.

A promise from the pharmaceutical company

The arrival of the pharmaceutical giant in Quebec was confirmed in April, during a press conference in the presence of Prime Ministers Justin Trudeau and François Legault.

At that time, the American manufacturer had already announced its intentions to establish a factory in Canada without, however, specifying the exact location.

Then, a few months later, Mayor Valérie Plante confirmed that it would be in the Montreal area.

The new Moderna factory should produce 30 million doses of messenger RNA (mRNA) vaccines annually with the possibility of producing up to 100 million if needed.

Some of the vaccines produced will be used against COVID-19, but others may be developed there, particularly against a range of other diseases, including influenza.

Moderna, which rose to prominence during the pandemic primarily for developing the COVID-19 vaccine Spikevax, is currently the world’s second-largest producer of messenger RNA vaccines against the COVID-19 virus.

Follow by Email